首页> 外文期刊>Annals of vascular surgery >Endovenous lasering versus ambulatory phlebectomy of varicose tributaries in conjunction with endovenous laser treatment of the great or small saphenous vein.
【24h】

Endovenous lasering versus ambulatory phlebectomy of varicose tributaries in conjunction with endovenous laser treatment of the great or small saphenous vein.

机译:静脉曲张与静脉曲张支静脉静脉摘除术结合静脉激光治疗大隐静脉或大隐静脉。

获取原文
获取原文并翻译 | 示例
           

摘要

Endovenous laser treatment (EVLT) is a widely used minimally invasive alternative to stripping of varicose veins involving the great and small saphenous veins. We expanded the applications to tributary varicosities and compared EVLT alone with combined EVLT and ambulatory phlebectomy. The study included 132 patients (76 males, 56 females) who were treated with EVLT and ambulatory phlebectomy. In addition, 133 patients (67 males, 66 females) were treated only with EVLT. Perforating vein reflux was identified in 65 patients in the combination group (49.2%) and in 121 patients (91.0%) in the EVLT only group (p=0.000). Postoperative complications and reoperation rates were compared between the two groups and the risk factors for reoperation analyzed. Ecchymosis (about 85%) and pain (>20%) were the major postoperative complications for both groups. There were no significant differences in the complications noted between the combination and EVLT only groups. During the follow-up period (25.6+/-12.8 months, range 15.5-37.3, in combination group; 11.8+/-8.2 months, range 1.3-18.5, in EVLT only group), residual tributary varicosities were noted in 12 patients (9.1%) in the combination group and in 11 (8.3%) in the EVLT only group (p=0.813). For patients who had reflux in the perforating veins, the reoperation rate was significantly higher compared to the patients without reflux in the perforating veins in each group (p=0.015 in combination group, p=0.006 in EVLT only group). The presence of perforating reflux was a significant risk factor (odds ratio=3.938, 95% confidence interval 1.05-14.78, p=0.042). EVLT as the sole therapy for the management of combined saphenous and tributary varicose veins was found to be safe and effective. However, longer follow-up is needed for confirmation of these findings.
机译:静脉内激光治疗(EVLT)是一种广泛使用的微创替代方法,可用于剥离涉及大隐静脉和小隐静脉的静脉曲张。我们将应用范围扩大到支流静脉曲张,并将单独的EVLT与EVLT和非卧床静脉摘除术进行了比较。该研究包括132例患者(76例男性,56例女性),他们接受了EVLT和非卧床静脉切除术治疗。此外,仅使用EVLT治疗了133例患者(男67例,女66例)。仅EVLT组中65例患者(49.2%)和121例患者(91.0%)发现了穿孔性静脉反流(p = 0.000)。比较两组的术后并发症和再手术率,并分析再次手术的危险因素。两组的主要术后并发症是瘀斑(约85%)和疼痛(> 20%)。联合用药组和仅EVLT组之间在并发症方面无显着差异。在随访期间(联合治疗组为25.6 +/- 12.8个月,范围为15.5-37.3;仅EVLT组为11.8 +/- 8.2个月,范围为13-18.5),在12例患者中发现了残留的支气管静脉曲张(组合组为9.1%),仅EVLT组为11(8.3%)(p = 0.813)。与穿孔静脉无反流的患者相比,穿孔静脉反流的患者每组的再手术率显着更高(联合组p = 0.015,仅EVLT组为p = 0.006)。射孔反流的存在是一个重要的危险因素(赔率= 3.938,95%置信区间1.05-14.78,p = 0.042)。 EVLT是治疗隐静脉和支流静脉曲张的唯一方法,被认为是安全有效的。但是,需要更长的随访来证实这些发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号